Wardwizard Healthcare Limited has announced that its 42nd Annual General Meeting will be held on Wednesday, September 30, 2026. The event is scheduled to commence at 3:00 pm through video conferencing or other audio-visual means.

The company published this information in compliance with Regulations 30, 44 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was disseminated via newspaper advertisements in the Financial Express and Pratahkal on September 1, 2026.

Meeting Details

Shareholders are required to attend the AGM remotely. The company will not dispatch physical copies of the AGM notice or the Annual Report for FY26. Instead, these documents will be made available electronically on the company’s website.

Members holding shares in physical form who have not registered their email addresses must submit Form ISR-1 to the Registrar and Transfer Agent. This form requires details such as Folio Number, name, scanned share certificates, and self-attested PAN and Aadhaar cards.

E-Voting Process

The company has enabled remote e-voting for all resolutions set out in the notice dated August 31, 2026. Shareholders can cast their votes electronically before or during the meeting.

Key instructions for shareholders include:

• Demat holders should follow the remote e-voting procedures outlined in the AGM notice.
• Physical shareholders without registered emails must update their details to participate in e-voting.
• The cut-off date for determining voting rights is specified in the official notice.

The complete notice and annual report are accessible at https://wardwizardhealthcare.com/ . Shareholders are advised to review the instructions for joining the virtual meeting and casting votes carefully.

Wardwizard Healthcare appointed Ms. Sathi Kundu as Additional Independent Woman Director and approved Mr. Yuvraj Priyadarshi’s elevation to Whole Time Director at its board meeting on August 31, 2026.

The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following recommendations from the Nomination and Remuneration Committee.

Board Appointments

Ms. Kundu, who holds a Bachelor of Arts and a Bachelor of Law from the University of Calcutta, brings over 15 years of legal experience. Her appointment as an Additional Independent Woman Director is effective immediately for a five-year term, subject to shareholder approval at the ensuing general meeting.

Mr. Priyadarshi, currently serving as CEO since November 14, 2025, and appointed as an Additional Director in March 2026, will assume the role of Whole Time Director starting September 30, 2026. This appointment is also subject to shareholder approval.

Director Profiles

Mr. Priyadarshi holds a Doctor of Optometry, Master of Science in Vision Science, and an MBA in Hospital Management. His professional background includes nine years with the World Health Organization in East Africa and two years as COO of Mombasa Eye Hospital.

Both directors have confirmed no relationships with other board members and no debarment by SEBI or other authorities.